Navigation Links
Tosoh Bioscience Introduces TSK-GEL SP-3PW (30), a Higher-Capacity Resin for the Purification of Insulin and Other Therapeutic Peptides and Small Proteins
Date:5/25/2010

Contains a smaller pore for improved resolution combined with unique selectivity and higher capacity than TSK-GEL SP-5PW resin for purification of insulin and other peptides and small proteins.

King of Prussia, PA (PRWEB) May 25, 2010 -- Tosoh Bioscience LLC, a provider of chromatographic solutions for biopurification, recently announced the introduction of a new line of TSK-GEL SP-3PW (30) resins for use in large scale purification of peptides and proteins. Packaging container volumes vary from 100mL up to 50L.

The TSK-GEL SP-3PW (30) resin is manufactured with a new production technology which yields a narrower particle size distribution. The 250Å pore of the particles is ideal for insulin and similarly sized molecules. The smaller pore size coupled with a higher ligand density account for the higher capacity over TSK-GEL 5PW resins.

The new polymer technology creates an additional selectivity tool for use by the developer for demanding separation problems. TSK-GEL SP-3PW (30) resins can be used for both polishing and intermediate purification process steps.

According to Al Jackewitz, marketing manager of process development resins at Tosoh Bioscience LLC, the new resin can be made in larger batches than the other TSK-GEL SP-5PW resins, and the new technology may be applied to other ligands in the near future.

The new resin is in inventory and now available for purchase.

TOSOH BIOSCIENCE LLC

Tosoh Bioscience LLC provides liquid chromatography products to laboratories and manufacturing plants in the Americas. While the majority of our customers are employed in biotechnology and pharmaceutical companies, our HPLC columns and systems are essential tools for sample analysis in most industries. Our dedicated size-exclusion HPLC system is predominantly used in the chemical and electronic industries. In the field of biotechnology, our preparative chromatography resins play a critical role in the purification of proteins and nucleic acids for medical purposes.

The company is a subsidiary of Tosoh Corporation in Japan, the parent of the Tosoh Group, which comprises 141 companies worldwide and a multiethnic workforce of over 10,000 people and generates sales of ¥827 billion (US$8.3 billion) annually.

For more information, please contact
Al Jackewitz
Biopurification Market Manager
Tosoh Bioscience LLC
484-805-1219

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb4043554.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Sangamo BioSciences and Collaborators Present Data in Fifteen Presentations Highlighting Broad Therapeutic Applications of ZFP Technology
2. YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting
3. YM BioSciences third quarter 2010 operational and financial results
4. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
5. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
6. YM BioSciences announces controlled equity offering
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
8. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
9. Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
10. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
11. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tosoh Bioscience Introduces TSK-GEL SP-3PW (30), a Higher-Capacity Resin for the Purification of Insulin and Other Therapeutic Peptides and Small Proteins 
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):